Cardiologia

M-A | Anticoagulantes orais diretos vs. warfarina em pacientes com fibrilação atrial.

10 Fev, 2022 | 12:53h

Direct Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials with Interaction Testing by Age and Sex – Circulation (link para o resumo – $ para o texto completo)

---

M-A | Colchicina após intervenção coronariana percutânea reduz significativamente o risco de eventos adversos cardiovasculares maiores em pacientes com doença arterial coronariana sintomática.

10 Fev, 2022 | 12:49h

Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention – openheart

Conteúdos relacionados:

---

Estudo mostra que infecções por COVID-19 aumentam o risco de problemas cardíacos até 1 ano depois.

8 Fev, 2022 | 15:02h

Comunicado de imprensa: COVID-19 infections increase risk of heart conditions up to a year later, study finds – Washington University in St. Louis

Estudo original: Long-term cardiovascular outcomes of COVID-19 – Nature Medicine

---

Estudo randomizado mostra que o uso regular de paracetamol aumenta a pressão arterial sistólica em cerca de 5 mmHg em comparação com placebo em pessoas hipertensas.

8 Fev, 2022 | 15:01h

Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial – Circulation (link para o resumo – $ para o texto completo)

Comentários:

Regular paracetamol use linked to higher blood pressure, study finds – University of Edinburg

Expert reaction to study looking at regular, long-term paracetamol use and blood pressure, in people with high blood pressures – Science Media Centre

Blood pressure warning over long-term paracetamol use – BBC

---

Diretrizes práticas para medidas de pressão arterial dentro e fora do consultório.

8 Fev, 2022 | 14:51h

2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement – Journal of Hypertension

---

Em pacientes em uso de anticoagulantes (orais diretos ou warfarina), infecção de trato respiratório não tratada com antibióticos está associada com aumento de mais de 2 vezes no risco de sangramento nos 0-14 dias seguintes.

8 Fev, 2022 | 14:45h

Respiratory tract infection and risk of bleeding in oral anticoagulant users: self-controlled case series – The BMJ

 

Comentário no Twitter

In new research of 1208 oral anticoagulant users, a greater than twofold increase was seen in the risk of major bleeding & clinically relevant non-major bleeding in the 0-14 days after a respiratory tract infection for which no antibiotics were prescribed https://t.co/wMIb2eDBKk

— The BMJ (@bmj_latest) December 21, 2021

 

---

Podcast | Dicas sobre palpitação.

8 Fev, 2022 | 14:36h

#320 Palpitations with Dr. Joshua Cooper – The Curbsiders

---

Revisão | Inteligência artificial (IA) e o cardiologista: quando mente, coração e máquina se unem.

8 Fev, 2022 | 14:32h

AI and the cardiologist: when mind, heart and machine unite – OpenHeart

---

Diretrizes ERC-ESICM sobre controle de temperatura após parada cardíaca em adultos.

7 Fev, 2022 | 13:45h

ERC-ESICM guidelines on temperature control after cardiac arrest in adults – Intensive Care Medicine (se o acesso a este link for pago, tente este)

Conteúdos relacionados:

M-A: In comatose survivors of cardiac arrest, targeted hypothermia is not associated with improved survival or better neurological outcomes vs. targeted normothermia.

RCT: In comatose survivors of out-of-hospital cardiac arrest, there was no difference in mortality and neurologic outcomes with mild (target temperature of 34 °C) vs. moderate therapeutic hypothermia (target temperature of 31 °C).

M-A: Targeted temperature management following out-of-hospital cardiac arrest – “Routine use of moderate or deep hypothermia in comatose survivors of OHCA may potentially be associated with more harm than benefit”.

RCT: In patients with coma after out-of-hospital cardiac arrest, targeted hypothermia did not improve outcomes.

 

Comentário no Twitter

Temperature control post ROSC @ERC_resus @ESICM guidelines:
🌡 monitor (core T) + prevent fever (min 72h)
❄️ insufficient evidence for/against 32-36°C or early cooling
Not recommended
🌡 active rewarming (mild hypothermia)
🚑 pre 🏥 cooling (cold fluids)https://t.co/w6X8fLInzf pic.twitter.com/U8TWG1oUyV

— Intensive Care Medicine (@yourICM) January 28, 2022

 

---

Recomendações EULAR para manejo de risco cardiovascular nas doenças reumáticas e musculoesqueléticas, incluindo lúpus eritematoso sistêmico e síndrome antifosfolípide.

7 Fev, 2022 | 13:43h

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome – Annals of Rheumatic Diseases

---